or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    CORT B 0.82 3.39
    BMY B 0.29 2.69
    LBPH A 0.02 2.67
    ITCI B -0.53 2.63
    JAZZ B 0.90 2.63
    VTRS A 0.08 2.48
    AXSM B 0.47 2.38
    EWTX C -0.19 2.38
    CTLT D -0.02 2.22
    ELAN D 0.19 2.18
    PRGO C -1.62 2.13
    RPRX D 0.74 2.10
    JNJ D 0.10 2.06
    ZTS D 0.07 2.04
    PFE F -0.55 2.00
    LLY F -2.08 1.98
    MRK F -0.33 1.90
    TARS C -1.37 1.86
    ARVN F 1.26 1.73
    OGN F 1.02 1.70
    SAVA D 2.88 1.68
    PBH A 0.00 1.60
    SUPN B -0.25 1.46
    AMPH F -0.33 1.39
    PCRX C 0.76 1.27
    LGND C 0.54 1.20
    ANIP D 0.00 1.04
    OCUL C 0.00 1.00
    COLL F 1.43 1.00
    AMRX C -0.48 0.89
    HROW D 0.31 0.88
    HRMY F -0.65 0.84
    WVE C -1.09 0.80
    MNMD C -4.50 0.78
    INVA D -0.76 0.67
    EYPT D 0.00 0.65
    LQDA F -1.78 0.61
    FULC F -0.84 0.60
    PLRX D -0.21 0.60
    ELVN C -2.50 0.45
    NUVB C 0.19 0.40
    EOLS F 0.04 0.36
    PHAT F 2.63 0.33
    XERS C -0.33 0.31

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Pharmaceutical Medicine Pharmaceutical Products Pain S&P 500 Alzheimer's Disease Animal Health Life Sciences Biotechnology Depression Diabetes Disease Drugs Hypertension Medication Neuroscience Pharmacology Suspension Acid
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

    Recent News for Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF & its Holdings

    Date Stock Title
    Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
    Nov 21 HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 HROW Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
    Nov 20 ZTS Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
    Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
    Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
    Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
    Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
    Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
    Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
    Nov 20 ANIP ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?
    Nov 20 LLY More companies covering weight loss drugs for their employees
    Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
    Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
    The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
    Exchange Traded Funds
    Back to the Main PILL Page...